Xiaofeng Ding | Biochemistry | Best Researcher Award

Posted on by sciencefather

Prof. Xiaofeng Ding | Biochemistry | Best Researcher Award

Hunan Normal University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Xiaofeng Ding (丁小凤) was born in Hunan Province, China, on October 21, 1979. Her academic journey began with a Bachelor’s degree in Biology from the College of Life Sciences, Hunan Normal University in 2002. Driven by a passion for molecular sciences, she pursued a Master’s degree in Biochemistry and Molecular Biology at the same institution, completing it in 2005 under the guidance of Dr. Jian Zhang. She further deepened her research expertise by earning a Ph.D. in Genetics from Nanjing University’s Model Animal Research Center in 2008, under the mentorship of renowned scientist Dr. Xiang Gao. This rigorous academic foundation provided her with the knowledge and research discipline essential for a career in biomedical sciences.

🧑‍🔬 Professional Endeavors

Prof. Ding’s professional journey showcases an impressive trajectory of advancement in academia and international research. Starting as a Lecturer in Biochemistry and Molecular Biology at Hunan Normal University in 2008, she was quickly promoted to Associate Professor by 2010 and became a full Professor by December 2017. Her international exposure includes a significant postdoctoral research position (2014–2016) at the University of New Mexico, USA, under Prof. Meilian Liu. Since January 2025, she has expanded her global footprint as a Research Scientist II at the National Primate Research Center, Tulane University, collaborating with Dr. Xuebin Qin on translational biomedical research.

🔬 Contributions and Research Focus

Prof. Ding’s research is anchored in biochemistry, molecular biology, and genetics with a strong focus on disease mechanisms, protein chemistry, and developmental biology. She has contributed extensively to understanding cellular pathways involved in metabolic disorders and cancer. Her work on tumor metabolism and protein interaction networks has potential implications for innovative treatments of chronic diseases and cancers. By integrating biochemical techniques with genetic tools, she bridges molecular mechanisms with therapeutic outcomes, especially in relation to human disease models.

🌟 Impact and Influence

Prof. Ding’s influence extends beyond laboratory research. As a dedicated mentor, she has nurtured young talents and inspired many students and researchers in China and abroad. Her leadership roles in scientific societies—including her position as director of the Hunan Society of Biochemistry and Molecular Biology and her membership in the Tumor Metabolism Professional Committee—highlight her commitment to shaping the future of biomedical science in China. Her work contributes to the broader understanding of disease biology and encourages interdisciplinary collaborations in health sciences.

📊 Academic Citations and Recognition

While the document does not specify citation metrics, Prof. Ding’s extensive publication record and international collaborations strongly suggest a growing academic footprint in biomedical research. Her association with global research hubs like the University of New Mexico and Tulane University adds visibility to her scholarly output. Her work in tumor metabolism and protein chemistry is increasingly cited by researchers in cancer biology, metabolic regulation, and therapeutic development.

🛠️ Technical and Research Skills

Prof. Ding is highly proficient in a wide array of laboratory and research techniques. Her technical strengths include molecular cloning, protein expression analysis, biochemical assays, and in vivo disease modeling. She is also skilled in advanced tools for genetic manipulation and cell biology, which she applies to elucidate complex signaling pathways. Her experience in both Chinese and American research laboratories equips her with a unique dual perspective in managing research infrastructure and interdisciplinary projects.

👩‍🏫 Teaching and Mentorship

As a professor and former associate professor at Hunan Normal University, Prof. Ding has played a central role in curriculum development and student training. She has guided undergraduate, postgraduate, and doctoral students through laboratory-based projects and theoretical studies in molecular biology. Her mentorship has contributed to the development of future researchers in life sciences and medical biotechnology.

🌱 Legacy and Future Contributions

Prof. Ding’s academic career reflects a legacy of commitment to research excellence and scientific leadership. Her long-term vision includes conducting groundbreaking research in disease biology and expanding collaborative networks across countries and disciplines. As a Research Scientist II at Tulane University and a leader in several biochemical societies, she is poised to make significant contributions to global health challenges through innovation and knowledge sharing. Her goal is to continue exploring disease mechanisms at the molecular level and translate discoveries into clinical strategies for cancer and metabolic disorders.

📖Notable Publications

AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage
Authors: G. Huang, M. Ouyang, K. Xiao, S. Xiang, X. Ding
Journal: Life Sciences
Year: 2024

A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms
Authors: P. Zhang, W. Luo, Z. Zhang, Y. Zeng, Z. Liu
Journal: Advanced Science
Year: 2024

Eosinophil-Associated Genes are Potential Biomarkers for Hepatocellular Carcinoma Prognosis
Authors: Q. Wang, Z. Zhang, H. Zhou, L. Li, X. Ding
Journal: Journal of Cancer
Year: 2024

Depletion of JunB increases adipocyte thermogenic capacity and ameliorates diet-induced insulin resistance
Authors: X. Zhang, X. Ding, C. Wang, Q.A. Wang, M. Liu
Journal: Nature Metabolism
Year: 2024

Teng Liu | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Prof. Teng Liu | Organic Chemistry | Best Researcher Award

Qujing Normal University, China

👨‍🎓Profiles

🎓 Academic Background and Early Career

Prof. Teng Liu has a strong foundation in chemistry, beginning with a Bachelor’s degree in Chemistry Education from Jiangxi Normal University (2006-2010). His academic journey continued at Yunnan University, where he obtained a Ph.D. in Organic Chemistry (2010-2016), specializing in asymmetric catalytic synthesis under the supervision of Prof. Zhihui Shao. His doctoral research focused on catalytic asymmetric isatin ketimines 1,2-addition reactions and nitrodienyne 1,4-addition reactions, contributing significantly to the field of stereoselective organic synthesis.

🔬 Professional Endeavors and Research Contributions

Prof. Teng Liu began his professional career as a Lecturer at Qujing Normal University (2017-2020) and was later promoted to Associate Professor in 2021. His research expertise lies in asymmetric catalytic synthesis and green chemistry, where he focuses on the development of efficient and sustainable synthetic methodologies for complex organic molecules. His work integrates chiral catalysis, selective cross-coupling reactions, and environmentally friendly organic transformations.

📑 Recent Research Achievements and Publications

In the last five years, Prof. Liu has published several high-impact SCI-indexed papers in renowned journals such as Organic Letters, Advanced Synthesis & Catalysis, and Green Chemistry. His notable publications include:

  • Base-Catalyzed Chalcogenative Annulation (Org. Lett., 2025): A novel approach for synthesizing 1,4-sulfa-/selena-zepanes using elemental sulfur/selenium.

  • Stepwise Synthesis of Pyrroloquinoline Diones (Adv. Synth. Catal., 2023): A one-pot method for constructing complex heterocyclic frameworks.

  • Cu(I)-Catalyzed Cascade Cyclization Reaction (Org. Lett., 2022): A groundbreaking method to construct pyrimido[5,4-b]indole derivatives, widely cited in the field.

  • Highly Selective C-P Cross-Coupling Reaction (Green Chem., 2019): A sustainable approach for the synthesis of ortho-amino triarylphosphine derivatives, advancing green chemistry methodologies.

His research has been highly cited and recognized in the field of organic chemistry, particularly in the areas of catalytic asymmetric synthesis and environmentally friendly chemical transformations.

🏆 Awards and Recognitions

Prof. Liu’s academic excellence has been acknowledged through several prestigious awards, including:

  • 2020: Excellent Doctoral Dissertation in Yunnan Province – Recognizing the significance of his Ph.D. research in asymmetric catalysis.

  • 2024: The Revitalize Yunnan Talent Support Program – Young Talents – A competitive award aimed at fostering outstanding young researchers in Yunnan Province.

🛠️ Research Focus and Impact

His current research interests center on asymmetric catalytic synthesis and green chemistry, aiming to develop highly efficient, selective, and eco-friendly synthetic methods. His work significantly impacts pharmaceutical synthesis, material science, and sustainable organic transformations. By integrating chiral catalysts and novel reaction mechanisms, he contributes to advancing both fundamental organic chemistry and practical applications in industrial synthesis.

🌱 Future Contributions and Academic Legacy

Looking ahead, Prof. Liu is committed to pushing the boundaries of green chemistry and asymmetric catalysis by exploring new catalytic systems, reaction pathways, and environmentally sustainable synthetic methodologies. His contributions to chemical education, research innovation, and sustainable chemical synthesis will continue to shape the next generation of scientists and drive progress in the field of organic chemistry.

📖Notable Publications

Base-Catalyzed Chalcogenative Annulation of N-Maleimido O-Aminobenzyl Alcohol with Elemental Sulfur/Selenium: Access to 1,4-Sulfa-/Selena-zepanes

Authors: Y. Wen, Yuanmin; T. Liu, Teng; S. Huang, Shuntao; Y. Ye, Yanqing; C. Huang, Chao

Journal: Organic Letters

Year: 2025

Brønsted-Acid Catalyzed Aldehyde Insertion to Construct C−X Bond: High Regio- and Chemoselectivity Synthesis of Dihydrobenzo[1,5]oxazocines and Pyrrolo[3,4-d]tetrahydropyrimidines

Authors: Y. Wen, Yuanmin; T. Liu, Teng; G. Zeng, Guiyun; C. He, Chixian; C. Huang, Chao

Journal: European Journal of Organic Chemistry

Year: 2025

Cs₂CO₃-Catalyzed Multi-Component One-Pot Stepwise Route for the Synthesis of Polysubstituted 2-Pyridones

Authors: S. Liu, Shitao; C. He, Chixian; G. Li, Guijun; X. Shen, Xianfu; T. Liu, Teng

Journal: ChemistrySelect

Year: 2024

Recent Advances in Total Synthesis of Prenylated Indole Alkaloids by Transition Metal-Catalyzed Reactions as the Key Step

Authors: T. Peng, Tianfeng; Y. Zhao, Yuxiang; S. Pu, Shaojian; Y. Miao, Yingchun; X. Shen, Xianfu

Journal: [No source information available]

Year: Not specified

Chemodivergence in Fluorine Source-Controlled Cascade Reaction of Aryne Precursors to Synthesize Pyrrolo[3,4-b]indoles and 3-Arylated Maleimides

Authors: Z. Wang, Zhuoyu; S. Huang, Shuntao; L. Yin, Lu; T. Liu, Teng; C. Huang, Chao

Journal: Journal of Organic Chemistry

Year: 2024

Sourav De | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Sourav De | Medicinal Chemistry | Best Researcher Award

Eminent College of Pharmaceutical Technology, India

👨‍🎓Profiles

🎓 Education and Academic Background

Dr. Sourav De is a distinguished researcher and educator currently affiliated with Eminent College of Pharmaceutical Technology, India. He earned his Doctor of Philosophy (Ph.D.) in Chemistry from the School of Advanced Sciences, Vellore Institute of Technology (VIT), India (March 2017 – December 2020). Under the guidance of Dr. S. K. Ashok Kumar, Professor, his doctoral thesis focused on the design, synthesis, characterization, and anticancer evaluation of various heterocycles and Ru(II)-arene-N^N, N^O, N^S complexes. His strong academic foundation also includes an M.Pharm in Pharmaceutical Chemistry from West Bengal University of Technology (2010–2012), where he graduated with a CGPA of 8.79 (First Class), and a B.Pharm from the University of North Bengal (2006–2010), securing 74% (First Class).

🔬 Research Interests

Dr. Sourav De’s research interests span a diverse range of medicinal chemistry and organometallic chemistry, with a strong emphasis on the therapeutic applications of organic and organometallic complexes. His key areas of focus include: Molecular Modeling and In-Silico Studies for drug discovery and computational chemistry. Chromogenic and Fluorogenic Sensors for biomedical and pharmaceutical applications. Cancer Research, particularly in the treatment of cervical, colon, breast, and brain tumors.

🏆 Research Projects

Dr. De has actively contributed to multiple academic research and technology development projects, showcasing his expertise in cancer theranostics, drug discovery, and molecular design. Notable projects include: DST-SERB Sponsored Project: He worked as a Project Assistant on the Development of novel 2-aryl benzothiazole/benzoxazole, quinoxaline, and phenanthroline analogues as fluorescent probes and cancer theranostics applications (EMR/2017/000816). Grant-in-Aid SEED Fund Research Project: As a Principal Investigator, he led a research project titled “In silico analysis of some ruthenium complexes as potential anti-cancer agents,” funded by Rs. 85,000 (AU/REG/NOT/2021/04/003). With over 11 years and 9 months of research experience, Dr. De has made impactful contributions to the fields of drug development and computational chemistry.

🛠️ Technical Skills

Dr. Sourav De possesses strong technical expertise across various analytical instruments, imaging techniques, and computational tools. His skill set includes: Instruments Handled: UV, FL, FTIR, CD spectroscopy, ELISA reader, Gel Doc, and HPLC. Imaging Techniques: Fluorescent Microscopy, Scanning Electron Microscopy (SEM), and Flow Cytometry. Computational and Analytical Tools: Molecular Modeling & Docking: AutoDock 4.2, AutoDock Vina, Chimera 1.11rc, Open Babel GUI. Data Analysis: Python for scientific computing and data visualization. Plotting and Molecular Visualization: Origin, ChemDraw, ChemSketch. Hands-on Experience: Cell culture, molecular biology, and bioinformatics for drug-target interactions and cancer research.

📚 Teaching Experience

Dr. De is an experienced educator specializing in pharmaceutical and medicinal chemistry. He has taught various subjects, including: Pharmaceutical Chemistry & Medicinal Chemistry, Organic and Inorganic Chemistry, Pharmaceutical Analysis & Instrumental Analysis. His teaching methodology combines practical applications and research-driven insights, ensuring students gain both theoretical knowledge and hands-on experience.

🌟 Future Research and Contributions

Dr. Sourav De is committed to advancing therapeutic drug design, molecular diagnostics, and cancer research. His future work aims to develop targeted anticancer drugs, bioactive organometallic complexes, and AI-driven molecular modeling techniques. With his expertise in pharmaceutical sciences and computational chemistry, he continues to make significant contributions to drug discovery and medicinal research.

📖Notable Publications

  • Pyridine: the scaffolds with significant clinical diversity

    • Authors: S De, AK SK, SK Shah, S Kazi, N Sarkar, S Banerjee, S Dey
    • Journal: RSC Advances
    • Year: 2022

  • Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer

    • Authors: S De, S Banerjee, SKA Kumar, P Paira
    • Journal: Mini Reviews in Medicinal Chemistry
    • Year: 2019

  • Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium (II)–arene-2-heteroarylbenzoxazole complexes

    • Authors: S De, SR Chaudhuri, A Panda, GR Jadhav, RS Kumar, P Manohar, …
    • Journal: New Journal of Chemistry
    • Year: 2019

  • Amberlite IR-120 (H) mediated “on water” synthesis of fluorescent Ruthenium (II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging

    • Authors: A Mondal, S De, S Maiti, B Sarkar, AK Sk, R Jacob, A Moorthy, P Paira
    • Journal: Journal of Photochemistry and Photobiology B: Biology
    • Year: 2018

  • Luminescent ruthenium (II)-para-cymene complexes of aryl substituted imidazo-1,10-phenanthroline as anticancer agents and the effect of remote substituents on cytotoxic activities

    • Authors: S De, RS Kumar, A Gauthaman, SKA Kumar, P Paira, A Moorthy, …
    • Journal: Inorganica Chimica Acta
    • Year: 2021

Ghanshyam Teli | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Mr. Ghanshyam Teli | Medicinal Chemistry | Best Researcher Award

School of Pharmacy, Sangam University, India

👨‍🎓Profiles

👨‍🎓 Early Academic Pursuits

Mr. Ghanshyam Teli’s academic journey began with a strong foundation in pharmacy. He earned his B. Pharmacy from Geetanjali University in 2019 with a commendable 73.7%. His academic pursuit continued with a M. Pharmacy from ISF College of Pharmacy in 2021, where he achieved an impressive 82%. Currently, he is pursuing his Ph.D. at Baba Farid University of Health Sciences, enhancing his expertise in the field. His early academic focus was on chemical synthesis and drug discovery, where he worked on several research projects related to anti-cancer agents and inhibitors of oncogenic pathways.

🧑‍🔬 Professional Endeavors

Mr. Teli has gained considerable professional experience, particularly in both academic and industrial settings. He has worked for 1.5 years as an Assistant Professor at the School of Pharmacy, Sangam University, Bhilwara, India, where he has been able to share his knowledge with students while continuing his research. His professional experience also includes 13 months at United Biotech Pvt Ltd as an Assistant R&D Chemist, where he contributed to several high-impact projects, including the synthesis of 4-Thiazolidinone derivatives and the development of Paclitaxel-HSA complex. Additionally, he spent 1 year as a Junior Research Fellow (JRF) at Acharya and B.M. Reddy College of Pharmacy in Bengaluru, further strengthening his research expertise.

🔬 Contributions and Research Focus

Mr. Teli's research contributions have primarily focused on drug design, synthesis, and evaluation, with a particular emphasis on creating compounds for anti-cancer treatment. His work on 4-thiazolidinone conjugates as potential anti-breast cancer agents is notable, along with his project on the discovery of triangular heterocyclic molecules to inhibit dual oncogenic pathways. His research aims to contribute to developing novel therapeutic strategies for cancer treatment, especially targeting HSP90 and BRAF kinases.

🌍 Impact and Influence

Mr. Teli's professional journey demonstrates his commitment to both academia and industry. His industrial experience has allowed him to engage in multi-step synthesis processes and biological evaluations, making a tangible impact on pharmaceutical development. As an educator, he strives to impart his knowledge and inspire the next generation of pharmacists, sharing insights from both his research and industry experience. His contributions aim to foster innovations in drug design and therapy, particularly in cancer treatments.

📚 Academic Cites and Recognition

While Mr. Teli’s academic work is still evolving, his research projects on drug discovery, particularly in the field of cancer, have the potential for future recognition and citations. His detailed work in the design and synthesis of bioactive compounds, particularly those related to anti-cancer and anti-breast cancer agents, is likely to gain traction and be cited by peers in the academic and research communities.

💻 Technical Skills

Mr. Teli is proficient in several technical aspects of pharmaceutical chemistry, including: Synthesis of chemical compounds and characterization through advanced spectroscopy techniques such as UV, IR, and 1H NMR. Docking studies and predicting ADMET properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity) for potential drug candidates. Handling specialized equipment such as Flash Chromatography, Column Chromatography, Rota-evaporator, Vacuum dryer, UV-Vis Spectrophotometer, and pH meter. Expertise in computational tools like ChemDraw, Autodock, Molegro Virtual Docker (MVD), Pymol, and Discovery Studio, which aid in the structure-activity relationship (SAR) analysis and molecular modeling.

👩‍🏫 Teaching Experience

As an Assistant Professor at the School of Pharmacy, Sangam University, Mr. Teli has honed his teaching skills, fostering a rich learning environment. His ability to explain complex concepts in pharmacy and drug design to students reflects his deep knowledge and communication skills. His teaching approach emphasizes practical application and encourages critical thinking. By sharing his industrial and research experiences, he connects students with real-world pharmaceutical challenges, aiming to inspire future innovations.

🌱 Legacy and Future Contributions

Mr. Teli’s ongoing research and academic efforts hold significant promise for the future of pharmacy education and drug discovery. His work on the synthesis of novel anti-cancer agents, especially those targeting key oncogenic pathways, has the potential to drive breakthroughs in cancer therapy. As he continues to pursue his Ph.D., Mr. Teli is committed to growing as a researcher and educator. He seeks to expand his knowledge, hone his technical skills, and make valuable contributions to drug development while guiding the next generation of pharmaceutical professionals.

📖Notable Publications

  • Synthetic product-based approach toward potential antileishmanial drug development
  • Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
    Journal: European Journal of Medicinal Chemistry
    Year: 2024
  • An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
  • Authors: Pal, R., Teli, G., Sengupta, S., Maji, L., Purawarga Matada, G.S.
    Journal: Journal of Biomolecular Structure and Dynamics
    Year: 2024
  • Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase
  • Authors: Teli, G., Pal, R., Maji, L., Purawarga Matada, G.S., Sengupta, S.
    Journal: Journal of Biomolecular Structure and Dynamics
    Year: 2024
  • Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
  • Authors: Pal, R., Teli, G., Matada, G.S.P., Dhiwar, P.S.
    Journal: Journal of Molecular Structure
    Year: 2023
  • The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis
  • Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
    Journal: European Journal of Medicinal Chemistry
    Year: 2023